ArticleCancers2023

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances.

Lucas Geyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.